Politics Polarizing Issues In Needle-Exchange Study

POINTED ASSERTION: Dennis Fisher contends that his clinical trial examining methods of obtaining clean syringes is both ethical and valid. Though a federally appointed panel of scientists and ethicists in December okayed the continuation of a controversial needle-exchange clinical trial at the University of Alaska, Anchorage, questions still linger over the ethical and scientific nature of the study. At the same time, the project offers a view of how science can be politicized. Despite survey

Written bySteven Benowitz

| 9 min read

Save for Later

Listen with Speechify

0:00

9:00

POINTED ASSERTION: Dennis Fisher contends that his clinical trial examining methods of obtaining clean syringes is both ethical and valid.

Though a federally appointed panel of scientists and ethicists in December okayed the continuation of a controversial needle-exchange clinical trial at the University of Alaska, Anchorage, questions still linger over the ethical and scientific nature of the study. At the same time, the project offers a view of how science can be politicized. Despite surveys showing the public would support clean-needle programs, which researchers say are effective in reducing disease, offering needles-through needle exchange or at pharmacies-is still perceived as encouraging drug use.

Study after study shows that needle-exchange programs (NEPs), in which drug users trade used syringes for clean ones, reduce the spread of blood-borne disease among injecting drug addicts. Several European countries, including France, Great Britain, and the Netherlands, as well as Australia and Canada, have had effective ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here